Posts

FDA HAS APPROVED FILSPARI™ (SPARSENTAN), THE FIRST-IN-CLASS NON-IMMUNOSUPPRESSIVE THERAPY FOR THE REDUCTION OF PROTEINURIA IN IgA NEPHROPATHY

0

FDA HAS APPROVED SUNLENCA (LENACAPAVIR), A NEW ANTIRETROVIRAL DRUG FOR THE TREATMENT OF HIV-1 IN ADULT PATIENTS WHO HAVE NOT RESPONDED TO OTHER TREATMENTS

0

SCIENTIFIC CONSENSUS IS THAT THERE IS NO CONSISTENT OR RELIABLE EVIDENCE THAT RANITIDINE INCREASES THE RISK OF ANY CANCER

0

How many pharmacists per country

0

EMA RECOMMENDS THE WITHDRAWAL OF MEDICINES CONTAINING ANTITUSSIVE PHOLCODINE

0

FDA approves Rebyota, a first-in-class medication for the prevention of recurrent clostridium difficile infections

0

Pharma Quiz 98

0

Did you know? NSAIDs facts

0